MX2020003661A - Formas de dosificacion de liquidos, metodos de fabricacion y uso. - Google Patents

Formas de dosificacion de liquidos, metodos de fabricacion y uso.

Info

Publication number
MX2020003661A
MX2020003661A MX2020003661A MX2020003661A MX2020003661A MX 2020003661 A MX2020003661 A MX 2020003661A MX 2020003661 A MX2020003661 A MX 2020003661A MX 2020003661 A MX2020003661 A MX 2020003661A MX 2020003661 A MX2020003661 A MX 2020003661A
Authority
MX
Mexico
Prior art keywords
dosage forms
manufacturing methods
liquid dosage
methods
cannabis
Prior art date
Application number
MX2020003661A
Other languages
English (en)
Inventor
Ben Geiling
Tom Shipley
Original Assignee
Canopy Growth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canopy Growth Corp filed Critical Canopy Growth Corp
Publication of MX2020003661A publication Critical patent/MX2020003661A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3482—Cannabis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Polymers & Plastics (AREA)
  • Botany (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

En el presente documento se describen formulaciones de cannabis y derivados de cannabis, métodos de fabricación y métodos de uso de la formulación en formas de dosificación oral, preferentemente en formas de bebidas.
MX2020003661A 2017-11-30 2018-11-30 Formas de dosificacion de liquidos, metodos de fabricacion y uso. MX2020003661A (es)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US201762592993P 2017-11-30 2017-11-30
US201762611851P 2017-12-29 2017-12-29
US201862618790P 2018-01-18 2018-01-18
US201862632279P 2018-02-19 2018-02-19
US201862632299P 2018-02-19 2018-02-19
US201862632272P 2018-02-19 2018-02-19
US201862632286P 2018-02-19 2018-02-19
US201862632289P 2018-02-19 2018-02-19
US201862632309P 2018-02-19 2018-02-19
US201862632295P 2018-02-19 2018-02-19
PCT/CA2018/051533 WO2019104442A1 (en) 2017-11-30 2018-11-30 Liquid dosage forms, methods of making and use

Publications (1)

Publication Number Publication Date
MX2020003661A true MX2020003661A (es) 2020-08-03

Family

ID=66664256

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020003661A MX2020003661A (es) 2017-11-30 2018-11-30 Formas de dosificacion de liquidos, metodos de fabricacion y uso.

Country Status (7)

Country Link
US (1) US20200289459A1 (es)
EP (1) EP3716945A4 (es)
AU (1) AU2018377175A1 (es)
CA (1) CA3076963C (es)
IL (1) IL273706A (es)
MX (1) MX2020003661A (es)
WO (1) WO2019104442A1 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020020850A2 (pt) 2018-04-09 2021-01-19 Ellevet Sciences Extrato de cânhamo para tratamento da dor em animais
CA3103504A1 (en) * 2018-06-15 2019-12-19 CannPal Animal Therapeutics Limited Cannabinoid composition and methods of treatment using the same
AU2019326314A1 (en) * 2018-08-20 2021-03-11 Hexo Operations Inc. Cannabis-infused product with controlled cannabinoid profile user experience
US20210236575A1 (en) * 2018-08-27 2021-08-05 Emerald Health Therapeutics Canada Inc. Therapeutic combinations of cannabinoids with curcumin
US20200215024A1 (en) * 2019-01-08 2020-07-09 Replennabis LLC Cannabinoid formulations for treating alcohol hangover
AU2020260090C9 (en) 2019-04-15 2023-08-31 Metagenics LLC Novel hemp and PEA formulation and its use
US11554098B2 (en) 2019-05-03 2023-01-17 HFL Partners, LLC Compositions comprising molecularly separated cannabinoids and terpene blends and methods of producing
JP7597780B2 (ja) * 2019-07-02 2024-12-10 ポートランド・テクノロジー・ホールディングス・エルエルシー 動物における疼痛、癌、およびてんかんの治療のための大麻抽出物
US12557843B2 (en) * 2019-07-15 2026-02-24 Raymond Louis Larson Other than cannabinoids, flavonoids, and terpenes
US20210169795A1 (en) * 2019-12-06 2021-06-10 Joshua Steindler Colloidal Suspensions of Plant Extracts in Aqueous Solutions
JP7675078B2 (ja) * 2019-12-09 2025-05-12 ニコベンチャーズ トレーディング リミテッド カンナビノイドを含む口腔用製品
SMT202300032T1 (it) * 2020-01-06 2023-03-17 Cannaxan Gmbh Preparazione ed uso di nano-formulazione di cannabis
US12545694B2 (en) 2020-01-08 2026-02-10 Chengdu Baiyu Pharmaceutical Co., Ltd. Cannabidiol derivatives, preparation method thereof and use thereof
EP4089084A4 (en) * 2020-01-08 2024-03-13 Chengdu Baiyu Pharmaceutical Co., Ltd. Cannabidiol derivative, and preparation method therefor and medical use thereof
US20210267907A1 (en) * 2020-02-27 2021-09-02 Prinova Flavors LLC Water-soluble microencapsulated cannabinoid extract powder and method of making the same
EP4125834A4 (en) * 2020-03-30 2024-05-08 Ojai Energetics PBC SYSTEMS, METHODS AND COMPOSITIONS FOR INFECTIONS
US20210308636A1 (en) * 2020-04-02 2021-10-07 Brian Brown Tetrahydrocannabinol emulsion and method of making and using
WO2022011393A1 (en) * 2020-07-08 2022-01-13 Shaman Naturals, Llc Compositions for preventing and treating diabetes
AU2020481908A1 (en) * 2020-12-16 2023-06-29 TARK, Hye Ryun Method for preparing vegetable oil emulsion using cannabidiol oil
WO2022153261A1 (en) * 2021-01-18 2022-07-21 Hadasit Medical Research Services & Development Company Ltd. Compositions and methods for treating bladder conditions
JP7776723B2 (ja) 2021-03-25 2025-11-27 日亜化学工業株式会社 収穫後植物の処理方法及び処理装置
JP2024528847A (ja) * 2021-07-22 2024-08-01 ニコベンチャーズ トレーディング リミテッド カンナビノイド及び／又はカンナビノイド類似体を含むナノエマルジョン
US12440454B2 (en) 2022-02-01 2025-10-14 Portland Technology Holdings Llc Pharmaceutical compositions containing hemp extract for administration to felines and related methods
US11666544B1 (en) * 2022-07-05 2023-06-06 Poviva Corp. Compositions and methods for treating hypertension
JP2026505492A (ja) * 2023-02-16 2026-02-13 ザ コカ・コーラ カンパニー 水不溶性機能性成分を含むエマルション
KR20260052075A (ko) * 2023-07-27 2026-04-17 디플로리아 엘엘씨 자폐증 및 관련 증상의 치료를 위한 cw1as1의 칸나비노이드 추출물의 조성물
KR20250072048A (ko) * 2023-11-16 2025-05-23 윤병인 항당뇨용 차바테 음료 조성물 및 이의 제조방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726916D0 (en) * 1997-12-19 1998-02-18 Danbiosyst Uk Nasal formulation
PT1542657E (pt) * 2002-08-14 2012-02-29 Gw Pharma Ltd Formulações líquidas canabinóides para administração pela mucosa
JP2011518876A (ja) * 2008-04-29 2011-06-30 ガンヴァント、 デビチャンド オスワル、 ホメオパシー製剤
GB201006200D0 (en) * 2010-04-14 2010-06-02 Ayanda As Composition
CA3089686A1 (en) * 2015-03-10 2016-09-15 Nanosphere Health Sciences, Llc A nanoparticle drug delivery comprising liquid lipids and cannabinoids encapsulated in a single layer of essential phospholipids
AU2016231788A1 (en) * 2015-03-19 2017-10-12 One World Cannabis Ltd Preparations of cannabis emulsions and methods thereof
IL262419B2 (en) * 2016-04-19 2024-08-01 Canna B Cure Ltd Cannabis-enriched enzymatically treated therapeutic composition
CN110636834A (zh) * 2017-02-15 2019-12-31 分子浸剂有限公司 制剂
CN107348282A (zh) * 2017-08-18 2017-11-17 黑龙江省科学院大庆分院 汉麻叶功能饮料及其制备方法

Also Published As

Publication number Publication date
WO2019104442A1 (en) 2019-06-06
EP3716945A4 (en) 2021-04-07
IL273706A (en) 2020-05-31
CA3076963A1 (en) 2019-06-06
US20200289459A1 (en) 2020-09-17
EP3716945A1 (en) 2020-10-07
AU2018377175A1 (en) 2020-04-16
CA3076963C (en) 2022-03-29

Similar Documents

Publication Publication Date Title
CO2019012353A2 (es) Formulaciones de anticuerpos anti-lag3 y coformulaciones de anticuerpos anti-lag3 y anticuerpos anti-pd-1
CL2019000793A1 (es) Moduladores de calpaínas y usos terapéuticos de los mismos.
CL2019000477A1 (es) Un esteroide 19 nor-c21-n-pirazolilo c3,3- disustituido cristalino.
MX379193B (es) Composiciones en solucion solida y su uso en inflamacion cronica.
CL2016002269A1 (es) Moduladores alostéricos del núcleo proteico de la hepatitis b.
MX2017001512A (es) Compuestos activos hacia bromodominios.
MX421186B (es) Constructos de anticuerpos.
CL2015002304A1 (es) Formas del metil {4,6-diamino-2- [1- (2-fluorobencil)-1h-pirazolo [3,4-b] piridino-3-il] pirimidino-5-il} metil carbamato
BR112018012145A2 (pt) partículas de entrega de pró-sabor
CL2015002835A1 (es) Nuevos derivados de piridina
ECSP18060848A (es) Derivados de 3-((hetero)aril)-alquil-8-amino-2-oxo-1,3-diaza-espiro-[ 4.5]-decano
CL2023002539A1 (es) Formas de dosificación pediátricas de vitamina d, métodos de elaboración y uso
ECSP18060820A (es) Derivados de 3-(carboxietil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]- decano
BR112017003219A2 (pt) formulação de acetato de abiraterona e métodos de uso
ECSP18060875A (es) Derivados de 8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano
CL2018001911A1 (es) Derivados de 3-(carboxietil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano
ECSP18060864A (es) Derivados de 3-(carboximetil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]- decano
MX389026B (es) Una composicion farmaceutica y el uso de la misma.
MX2018005987A (es) Compuestos heterociclicos para el tratamiento de enfermedades.
MX2018005350A (es) Formulacion de combinacion de dosis fija, eflornitina y sulindaco.
CR20160369A (es) Composiciones para uso en el tratamiento de afecciones alérgicas
EA201991319A1 (ru) Вакцины аттенуированного свиного гриппа и способы их изготовления и применения
CO2019010605A2 (es) Material mixto de caucho y procedimiento para obtener el mismo campo tecnológico
PH12018502139A1 (en) Phosphaplatin liquid formulations
MX2017007596A (es) Procedimiento para fabricar partículas de resinato de fenilefrina; partículas de resinato de fenilefrina; y uso de las partículas de resinato de fenilefrina en formulaciones farmacéuticas.